
Hepatitis C is a preventable but potentially life-threatening blood-borne virus. It primarily affects the liver and, if untreated, can lead to cirrhosis (scar damage) and cancer.
When direct-acting antivirals for hepatitis C arrived in 2016, they were described as a game changer. They cured chronic hepatitis C in more than 95% of cases. So Australia adopted the World Health Organization’s target to eliminate hepatitis C by 2030.